No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Gary Rabin?

Mr. Gary H. Rabin

Chairman and Chief Executive Officer

Ocata Therapeutics, Inc.

HQ Phone: (508) 756-1212

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Ocata Therapeutics, Inc.

33 Locke Drive

Marlborough, Massachusetts 01752

United States

Company Description

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine. Ocata's most advanced products are in clinical trials for the treatment of Stargard ... more

Find other employees at this company (27)

Background Information

Employment History

Chief Executive Officer


Chief Executive Officer and Investor Conference


Managing Director, Co-Head and Founder of the Telecommunications and Industry Group

ING companies

Managing Partner

GR Advisors, LLC


Chairman and Chief Executive Officer
Advanced Cell Technology , Inc.

Web References (153 Total References)

Nonetheless, on May 1, 2013, the ... [cached]

Nonetheless, on May 1, 2013, the CEO and Chairman of Ocata Therapeutics, Gary Rabin, wrote in a written interview for the Knoepfler Lab Stem Cell Blog that, "Our IP position includes claims around inducing pluripotency using Oct-4, as well as zero footprint reprogramming using vectorless technology.

Interview with Gary Rabin of Advanced Cell Technology (ACT). Knoepfler Lab Stem Cell Blog, [blog]. Available at: Web. 9 Apr. 2015. [19] Fate Therapeutics (2012). Fate Therapeutics and BD Biosciences Launch BD SMC4 to Improve Cellular Reprogramming and iPS Cell Culture Applications [Press release]. June 11, 2012.

CompanyNews [cached]

"This settlement ends the cost and uncertainty associated with this litigation and resolves all of the litigation relating to the debentures, which have represented an ongoing cost and distraction for both management and our shareholders," said Gary Rabin, chairman and CEO of ACT.

CompanyNews [cached]

Gary Rabin, chairman and CEO, in reference to the conference call scheduled for 4:30 p.m. EST today, said, "We are extremely pleased with these results, and plan to visually share a few examples today.

CompanyNews [cached]

"Having completed the second, higher-dose patient cohort in all three of our clinical trials in the U.S. and Europe, we are now officially at the halfway point in all three, which we find very gratifying," commented Gary Rabin, chairman and CEO of ACT.

CompanyNews [cached]

Advanced Cell Technology, Inc. ("ACT") (ACTC), a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will present at Biotech Showcase 2013 on Tuesday, Jan. 8, in San Francisco.

A link to a live webcast of Mr. Rabin's presentation will be available on the Events section of the ACT website and the PowerPoint presentation will be available on thePresentation section.

Similar Profiles

Other People with this Name

Other people with the name Rabin

Alix Rabin
Praxis Consulting Group Inc

Jordan Rabin
Broadview Networks Inc

Jeff Rabin
University of the Incarnate Word

Bonnie Rabin

Tali Rabin
Computer Generated Solutions Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory